{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:54:09Z","timestamp":1792068849108,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2025ZD050"],"award-info":[{"award-number":["2025ZD050"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["National Traditional Chinese Medicine People's Education Letter [2025] No. 181"],"award-info":[{"award-number":["National Traditional Chinese Medicine People's Education Letter [2025] No. 181"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["24YDTPJ00710"],"award-info":[{"award-number":["24YDTPJ00710"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bmcl.2026.130758","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:15:28Z","timestamp":1788045328000},"page":"130758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Semi-synthesis and activity study of \u03b1-mangostin ether derivatives bearing N-heterocyclic side chains as multitarget-directed ligands against AD"],"prefix":"10.1016","volume":"142","author":[{"given":"Bokai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bmcl.2026.130758_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70131","article-title":"Multi-target drug design in Alzheimer\u2019s disease treatment: emerging technologies, advantages, challenges, and limitations","volume":"13","author":"Hossain","year":"2025","journal-title":"Pharmacol Res Perspect"},{"issue":"17","key":"10.1016\/j.bmcl.2026.130758_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202500053","article-title":"The evolution of AChE inhibitors in Alzheimer\u2019s disease: from single-target to multi-target ligands","volume":"26","author":"Mehta","year":"2025","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmcl.2026.130758_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107152","article-title":"A comprehensive review of multi-target directed ligands in the treatment of Alzheimer\u2019s disease","volume":"144","author":"Pathak","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2026.130758_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102990","article-title":"Unveiling Alzheimer\u2019s disease (1901-2025): historical insights, global burden, biological mechanisms, diagnostics, and therapeutic strategies","volume":"114","author":"Baviskar","year":"2026","journal-title":"Ageing Res Rev"},{"issue":"14","key":"10.1016\/j.bmcl.2026.130758_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146980","article-title":"Alzheimer\u2019s disease etiology hypotheses and therapeutic strategies: a perspective","volume":"26","author":"Scarano","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmcl.2026.130758_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118584","article-title":"Research progress of curcumin and its derivatives as anti-inflammatory agents: from molecular mechanism to clinical application","volume":"306","author":"Wu","year":"2026","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2026.130758_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157238","article-title":"Plant-derived natural products modulate astrocyte function: therapeutic strategies for Alzheimer\u2019s disease","volume":"148","author":"Wei","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130758_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-025-04446-8","article-title":"Alzheimer\u2019s disease: unraveling role of xanthone derivatives and nanocarriers","volume":"399","author":"Suhaili","year":"2026","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.bmcl.2026.130758_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102772","article-title":"Xanthones as neuroprotective agents: a comprehensive review of their role in the prevention and treatment of neurodegenerative diseases","volume":"109","author":"Das","year":"2025","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.bmcl.2026.130758_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173950","article-title":"A review on \u03b1-mangostin as a potential multi-target-directed ligand for Alzheimer\u2019s disease","volume":"897","author":"Yang","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"19","key":"10.1016\/j.bmcl.2026.130758_bb0055","first-page":"11080","article-title":"Effects of \u03b1-mangostin derivatives on the Alzheimer\u2019s disease model of rats and their mechanism: a combination of experimental study and computational systems pharmacology analysis","volume":"5","author":"Chen","year":"2020","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130758_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2025.111318","article-title":"Discovery of \u03b1-Mangostin derivatives as novel PDE4 inhibitors for the treatment of Alzheimer\u2019s disease: an artificial intelligence-driven synergized strategy","volume":"37","author":"Sang","year":"2026","journal-title":"Chin Chem Lett"},{"issue":"17","key":"10.1016\/j.bmcl.2026.130758_bb0065","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.3390\/ijms21176211","article-title":"Mangosteen pericarp and its bioactive xanthones: potential therapeutic value in Alzheimer\u2019s disease, Parkinson\u2019s disease, and depression with pharmacokinetic and safety profiles","volume":"21","author":"Do","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.bmcl.2026.130758_bb0070","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1080\/14786419.2014.986729","article-title":"Chemistry of \u03b1-mangostin. Studies on the semisynthesis of minor xanthones from Garcinia mangostana","volume":"29","author":"Morelli","year":"2015","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmcl.2026.130758_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128316","article-title":"Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"49","author":"Wu","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130758_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400671","article-title":"Design, synthesis, biological evaluation and X-ray single crystal structure of novel CADD-based \u03b1-mangostin derivatives: multifunctional ligands against Alzheimer\u2019s disease","volume":"358","author":"Chen","year":"2025","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmcl.2026.130758_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118852","article-title":"Structure-based virtual screening, in vitro and in silico analysis identified novel potent m6A demethylase FTO inhibitors as promising neurotherapeutic agents","volume":"312","author":"Irisarri","year":"2026","journal-title":"Eur J Med Chem"},{"issue":"18","key":"10.1016\/j.bmcl.2026.130758_bb0090","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1080\/07391102.2022.2139762","article-title":"Design, synthesis and molecular docking and ADME studies of novel hydrazone derivatives for AChE inhibitory, BBB permeability and antioxidant effects","volume":"41","author":"Osmaniye","year":"2023","journal-title":"J Biomol Struct Dyn"},{"issue":"4","key":"10.1016\/j.bmcl.2026.130758_bb0095","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine","volume":"110","author":"Mesulam","year":"2002","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.bmcl.2026.130758_bb0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0969-2126(99)80040-9","article-title":"Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs","volume":"7","author":"Kryger","year":"1999","journal-title":"Structure"},{"issue":"42","key":"10.1016\/j.bmcl.2026.130758_bb0105","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.bmcl.2026.130758_bb0110","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.3390\/ijms22179290","article-title":"Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis","volume":"22","author":"Walczak-Nowicka","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.bmcl.2026.130758_bb0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/cbic.200500223","article-title":"The alpha-to-beta conformational transition of Alzheimer\u2019s Abeta-(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding","volume":"7","author":"Tomaselli","year":"2006","journal-title":"Chembiochem"},{"key":"10.1016\/j.bmcl.2026.130758_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.112086","article-title":"Synthesis, single crystal characterization and anti-AD activities of a novel complex of cu(II) with in situ formed protonated chrysin derivative ligand","volume":"239","author":"Liu","year":"2023","journal-title":"J Inorg Biochem"},{"issue":"1","key":"10.1016\/j.bmcl.2026.130758_bb0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/jf0305231","article-title":"Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay","volume":"52","author":"D\u00e1valos","year":"2004","journal-title":"J Agric Food Chem"},{"issue":"5","key":"10.1016\/j.bmcl.2026.130758_bb0130","article-title":"Antioxidant properties of embelin in cell culture. Electrochemistry and theoretical mechanism of scavenging. Potential scavenging of superoxide radical through the cell membrane","volume":"9","author":"Caruso","year":"2020","journal-title":"Antioxidants (Basel)"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26002258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X26002258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:36:31Z","timestamp":1792067791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X26002258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":26,"alternative-id":["S0960894X26002258"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130758","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semi-synthesis and activity study of \u03b1-mangostin ether derivatives bearing N-heterocyclic side chains as multitarget-directed ligands against AD","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2026.130758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130758"}}